Concepedia

Rosmely Hernandez

RH

Statistics

Publications

8

Citations

260

H-Index

8

Active since

2019

Affiliations

University of Miami(Current)

Medical University of Vienna

Gladstone Institutes

Innovative Genomics Institute

Parker Institute for Cancer Immunotherapy

Rosmely Hernandez is an author at University of Miami specializing in life sciences, immunology, and antitumor t cell responses.

ORCID

Publications per year

2019–2025

8

Publications

8

Base-editing mutagenesis maps alleles to tune human T cell functions

Ralf Schmidt, Carl C. Ward, Rama Dajani et al. · Nature · 2023 · 93 citations · Full text

, , +12

Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms

Natasha C. Ward, Jen Bon Lui, Rosmely Hernandez et al. · Diabetes · 2020 · 45 citations · Full text

, , +17

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4<sup>+</sup> and CD8<sup>+</sup> neoantigen-specific T cells to promote antitumor immunity

Rosmely Hernandez, Kathryn M LaPorte, Sunnie Hsiung et al. · Journal for ImmunoTherapy of Cancer · 2021 · 32 citations · Full text

, , +17

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8<sup>+</sup> T cells

Kathryn M LaPorte, Rosmely Hernandez, Alicia Santos Savio et al. · Journal for ImmunoTherapy of Cancer · 2023 · 29 citations · Full text

, , +17

Chromosomally-Encoded Yersinia pestis Type III Secretion Effector Proteins Promote Infection in Cells and in Mice

Sara Schesser Bartra, Cherish D. Lorica, Lianfen Qian et al. · Frontiers in Cellular and Infection Microbiology · 2019 · 18 citations · Full text

, , +17

1–5 of 8